Ghana vs Senegal: Cause of death, by non-communicable diseases, ages 5-14, male
Ghana
22.4%
in 2021
Senegal
22.3%
in 2021
Ghana rank
138th
Senegal rank
139th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Ghana
- Senegal
How they compare
Ghana currently reports 22.4% against 22.3% in Senegal, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Ghana ahead.
Ghana ranks 138th and Senegal ranks 139th of 185 countries.
Ghana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ghana | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.5% | 15.2% | 5.3% | Ghana |
| 2010s | 22.7% | 21.7% | 0.9% | Ghana |
| 2020s | 22.9% | 22.3% | 0.6% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Ghana or Senegal?
- Ghana, at 22.4% against 22.3% in Senegal as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Ghana and Senegal?
- 0.1%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Senegal?
- 6 years are reported by both, from 2000 to 2021.
- How do Ghana and Senegal rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Ghana ranks 138th and Senegal ranks 139th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.